Deep Track Capital, LP

GREENWICH, CT · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$5.94B2026 Q3+ $196.5M options (notional, not included)
Positions74
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.43.3%

Deep Track Capital, LP reported 74 positions worth $5.94B as of September 30, 2026 (13F filed November 16, 2026). Largest holding: GH (8.2%). Biggest move: exit ALNY ($248.3M).

10 / 74 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 GHGuardant Health$500.4M8.15%2,805,677——-19.2%
▸ 2 BMRNBiomarin Pharmaceutical$382.5M6.23%6,374,395——-3.3%
▸ 3 IMVTImmunovant$309.5M5.04%9,160,801——-1.5%
▸ 4 TARSTarsus Pharmaceuticals$299.3M4.87%3,806,768——+2.1%
▸ 5 MANEVeradermics$230.3M3.75%1,900,000——+5.6%
▸ 6 VERAVera Therapeutics$226.0M3.68%7,000,000——-13.0%
▸ 7 PCVXVaxcyte$199.9M3.26%3,513,069——+8.3%
▸ 8 ALKSAlkermes$182.3M2.97%4,500,000——+14.8%
▸ 9 OCULOcular Therapeutix$168.3M2.74%21,939,625——-21.6%
▸ 10 UTHRUnited Therapeutics$162.6M2.65%300,040——+8.5%

Pro Feature

The remaining 64 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Deep Track Capital, LP hold as of Q3 2026?

Deep Track Capital, LP reported 74 positions worth $5.94B in its Q3 2026 13F filing. Largest positions: GH (8.2%), BMRN (6.2%), IMVT (5.0%), TARS (4.9%) and MANE (3.8%).

What did Deep Track Capital, LP buy in Q3 2026?

New positions: INSM, TEM, LTGO, BBIO and ATTOVIA THERAPEUTICS INC (20 in all). Added to: BMRN, VERA, UTHR, WGS and ALKS (17 in all).

What did Deep Track Capital, LP sell in Q3 2026?

Reduced: GH, GRAL, ORKA, DFTX and MBX (19 in all). Sold out entirely: ALNY, NUVLEUR, IONS, ATAI and CYTK (13 in all).

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.